BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26853398)

  • 1. Triple negative epithelial ovarian cancer: "A new entity".
    Jain P; Jain A; Dubashi B
    Indian J Cancer; 2015; 52(2):190. PubMed ID: 26853398
    [No Abstract]   [Full Text] [Related]  

  • 2. Subtype specific elevated expression of hyaluronidase-1 (HYAL-1) in epithelial ovarian cancer.
    Yoffou PH; Edjekouane L; Meunier L; Tremblay A; Provencher DM; Mes-Masson AM; Carmona E
    PLoS One; 2011; 6(6):e20705. PubMed ID: 21695196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the contribution of immunologically-detectable HER2, steroid receptors and of the "triple-negative" tumor status to disease-free and overall survival of women with epithelial ovarian cancer.
    de Toledo MC; Sarian LO; Sallum LF; Andrade LL; Vassallo J; de Paiva Silva GR; Pinto GA; Soares FA; Fonseca CD; Derchain SF
    Acta Histochem; 2014 Apr; 116(3):440-7. PubMed ID: 24238473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The dualistic model and extraovarian origin theory of ovarian epithelial cancer].
    Kong BH
    Zhonghua Fu Chan Ke Za Zhi; 2013 Apr; 48(4):310-3. PubMed ID: 23902820
    [No Abstract]   [Full Text] [Related]  

  • 5. [Recent advances on ovarian epithelial cancer: definition, subtypes and pathologic features].
    Guo DH; Zheng WX
    Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):624-8. PubMed ID: 24314254
    [No Abstract]   [Full Text] [Related]  

  • 6. [Advances in origin and pathogenesis of epithelial ovarian cancer].
    Liu CR; Zheng WX
    Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):569-72. PubMed ID: 22169654
    [No Abstract]   [Full Text] [Related]  

  • 7. 'Triple negative' epithelial ovarian cancer and pathologic markers for prognosis.
    Liu N; Wang X; Sheng X
    Curr Opin Obstet Gynecol; 2011 Feb; 23(1):19-23. PubMed ID: 21150601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathology of ovarian cancer.
    Sanseverino F; D'Andrilli G; Petraglia F; Giordano A
    Anal Quant Cytol Histol; 2005 Jun; 27(3):121-4. PubMed ID: 16121632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible origin of ovarian cancer in the fallopian tubes.
    Venkatesan P
    Lancet Oncol; 2017 Dec; 18(12):e714. PubMed ID: 29103868
    [No Abstract]   [Full Text] [Related]  

  • 10. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 11. Improved classification of epithelial ovarian cancer: results of 3 danish cohorts.
    Steffensen KD; Waldstrøm M; Grove A; Lund B; Pallisgård N; Jakobsen A
    Int J Gynecol Cancer; 2011 Dec; 21(9):1592-600. PubMed ID: 21926912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
    Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X
    Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The revised 2014 FIGO staging system for epithelial ovarian cancer: Is a subclassification into FIGO stage IVA and IVB justified?
    Ataseven B; Harter P; Grimm C; Heitz F; Heikaus S; Traut A; Kahl A; Kurzeder C; Prader S; du Bois A
    Gynecol Oncol; 2016 Aug; 142(2):243-7. PubMed ID: 27208538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dualistic classification of epithelial ovarian cancer: Is it clinically relevant?].
    Devouassoux-Shisheboran M; Genestie C; Ray-Coquard I
    Bull Cancer; 2016 Mar; 103(3):252-8. PubMed ID: 26853278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A new classification of ovarian tumors].
    Frank GA; Moskvina LV; Andreeva YY
    Arkh Patol; 2015; 77(4):40-50. PubMed ID: 26485779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kindlin-2 inhibits serous epithelial ovarian cancer peritoneal dissemination and predicts patient outcomes.
    Ren C; Du J; Xi C; Yu Y; Hu A; Zhan J; Guo H; Fang W; Liu C; Zhang H
    Biochem Biophys Res Commun; 2014 Mar; 446(1):187-94. PubMed ID: 24583125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulated estrogen receptor signaling in the hypothalamic-pituitary-ovarian axis leads to ovarian epithelial tumorigenesis in mice.
    Laws MJ; Kannan A; Pawar S; Haschek WM; Bagchi MK; Bagchi IC
    PLoS Genet; 2014 Mar; 10(3):e1004230. PubMed ID: 24603706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FBXW7 is involved in the acquisition of the malignant phenotype in epithelial ovarian tumors.
    Kitade S; Onoyama I; Kobayashi H; Yagi H; Yoshida S; Kato M; Tsunematsu R; Asanoma K; Sonoda K; Wake N; Hata K; Nakayama KI; Kato K
    Cancer Sci; 2016 Oct; 107(10):1399-1405. PubMed ID: 27486687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian seromucinous carcinoma: report of a series of a newly categorized and uncommon neoplasm.
    Taylor J; McCluggage WG
    Am J Surg Pathol; 2015 Jul; 39(7):983-92. PubMed ID: 25723110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and clinical significance of estrogen-regulated long non-coding RNAs in estrogen receptor α-positive ovarian cancer progression.
    Qiu JJ; Ye LC; Ding JX; Feng WW; Jin HY; Zhang Y; Li Q; Hua KQ
    Oncol Rep; 2014 Apr; 31(4):1613-22. PubMed ID: 24481591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.